CDTX logo

Cidara Therapeutics (CDTX) Selling, General & Administrative Expenses

Annual SGA

$18.33 M
-$2.21 M-10.77%

December 31, 2023

Summary

Performance

1-Year Change

-10.77%

3-Year Change

+15.31%

5-Year Change

+29.63%

15-Year Change

+42.14%

CDTX SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

38.41%
CDTX annual SGA is higher than 38.41% of companies in Healthcare sector

High & Low

All-time High

$20.55 M
CDTX annual SGA is currently -10.77% below its historical high of $20.55 million

3-Year Low

$18.33 M
CDTX annual SGA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
CDTX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 22, 2025
CDTX next annual earnings announcement is scheduled for Apr 22, 2025

OtherCDTXexpensesmetrics:

Annual Total Expenses

$88.39 M
CDTX annual total expenses is $88.39 million

Annual Operating Expenses

$86.86 M
CDTX annual total operating expenses is $86.86 million

Annual Cost Of Goods Sold

$1.52 M
CDTX annual cost of goods sold is $1.52 million

Annual Interest Expense

-
CDTX annual interest expense value is unknown

Quarterly SGA

$4.96 M
+$219.00 K+4.61%

September 30, 2024

Summary

Performance

3-Month Change

+4.61%

1-Year Change

-39.45%

3-Year Change

+11.4%

5-Year Change

+11.4%

CDTX Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

38.09%
CDTX quarterly SGA is higher than 38.09% of companies in Healthcare sector

High & Low

All-time High

$8.20 M
CDTX quarterly SGA is currently -39.45% below its historical high of $8.20 million

3-Year Low

$3.18 M
CDTX quarterly SGA is currently +56.08% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CDTX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 22, 2025
CDTX next earnings announcement is scheduled for Apr 22, 2025

OtherCDTXexpensesmetrics:

Quarterly Total Expenses

$17.39 M
CDTX quarterly total expenses is $17.39 million

Quarterly Operating Expenses

$17.39 M
CDTX quarterly total operating expenses is $17.39 million

Quarterly Cost Of Goods Sold

-
CDTX quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
CDTX quarterly interest expense value is unknown

TTM SGA

-$2.00 B
-$134.66 M-7.24%

September 30, 2024

Summary

Performance

3-Month Change

-9069.59%

1-Year Change

-10525.38%

3-Year Change

-10176.8%

5-Year Change

-10176.8%

CDTX TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

23.95%
CDTX TTM SGA is higher than 23.95% of companies in Healthcare sector

High & Low

All-time High

-$13.30 M

3-Year Low

-$2.00 B
CDTX TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
CDTX previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 22, 2025
CDTX next earnings announcement is scheduled for Apr 22, 2025

OtherCDTXexpensesmetrics:

Annual Total Expenses

$88.39 M
CDTX annual total expenses is $88.39 million

Annual Operating Expenses

$86.86 M
CDTX annual total operating expenses is $86.86 million

TTM Cost Of Goods Sold

-
CDTX TTM cost of goods sold value is unknown

TTM Interest Expense

-
CDTX TTM interest expense value is unknown

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$18.33 M
CDTX annual SGA is $18.33 million

Annual Operating Expenses

$86.86 M
CDTX annual total operating expenses is $86.86 million

Annual Cost Of Goods Sold

$1.52 M
CDTX annual cost of goods sold is $1.52 million

CDTX Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-10.8%-39.5%-10000.0%
3 y3 years+15.3%+11.4%-10000.0%
5 y5 years+29.6%+11.4%-10000.0%

CDTX Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-10.8%at low-39.5%+56.1%-39.2%at low
5 y5-year-10.8%+15.3%-39.5%+56.1%-101.6%at low
alltimeall time-10.8%+6640.1%-39.5%+1666.9%<-9999.0%at low

Cidara Therapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$4.96 M(+4.6%)
$23.91 M(+7.5%)
Jun 2024
-
$4.75 M(-20.9%)
$22.24 M(+7.6%)
Mar 2024
-
$6.00 M(-26.9%)
$20.68 M(+8.1%)
Dec 2023
$18.33 M(-10.8%)
$8.20 M(+148.6%)
$19.14 M(+16.5%)
Sep 2023
-
$3.30 M(+3.7%)
$16.43 M(-13.1%)
Jun 2023
-
$3.18 M(-28.6%)
$18.91 M(-4.5%)
Mar 2023
-
$4.46 M(-18.8%)
$19.80 M(-3.6%)
Dec 2022
$20.55 M(+9.6%)
$5.49 M(-5.1%)
$20.55 M(+2.5%)
Sep 2022
-
$5.78 M(+41.9%)
$20.04 M(+6.2%)
Jun 2022
-
$4.07 M(-21.7%)
$18.87 M(-1.5%)
Mar 2022
-
$5.20 M(+4.5%)
$19.16 M(+2.3%)
Dec 2021
$18.74 M(+17.9%)
$4.98 M(+8.1%)
$18.74 M(+4.7%)
Sep 2021
-
$4.61 M(+5.4%)
$17.91 M(+5.4%)
Jun 2021
-
$4.37 M(-8.6%)
$16.99 M(+2.4%)
Mar 2021
-
$4.78 M(+15.3%)
$16.59 M(+4.3%)
Dec 2020
$15.90 M(-2.1%)
$4.15 M(+12.5%)
$15.90 M(-1.6%)
Sep 2020
-
$3.69 M(-7.1%)
$16.16 M(-5.2%)
Jun 2020
-
$3.97 M(-3.1%)
$17.04 M(+2.7%)
Mar 2020
-
$4.09 M(-7.0%)
$16.60 M(+2.2%)
Dec 2019
$16.24 M
$4.41 M(-3.7%)
$16.24 M(+5.5%)
Sep 2019
-
$4.57 M(+29.7%)
$15.38 M(+7.9%)
Jun 2019
-
$3.52 M(-5.6%)
$14.26 M(-0.1%)
DateAnnualQuarterlyTTM
Mar 2019
-
$3.73 M(+5.2%)
$14.27 M(+0.9%)
Dec 2018
$14.14 M(+9.7%)
$3.55 M(+3.0%)
$14.14 M(+2.3%)
Sep 2018
-
$3.45 M(-2.4%)
$13.82 M(+2.7%)
Jun 2018
-
$3.53 M(-2.2%)
$13.46 M(+0.8%)
Mar 2018
-
$3.61 M(+11.8%)
$13.35 M(+3.5%)
Dec 2017
$12.90 M(+1.3%)
$3.23 M(+4.5%)
$12.90 M(+1.5%)
Sep 2017
-
$3.09 M(-9.8%)
$12.71 M(-3.9%)
Jun 2017
-
$3.42 M(+8.5%)
$13.23 M(+0.3%)
Mar 2017
-
$3.15 M(+3.7%)
$13.20 M(+3.6%)
Dec 2016
$12.74 M(+44.1%)
$3.04 M(-15.6%)
$12.74 M(+5.6%)
Sep 2016
-
$3.61 M(+6.4%)
$12.06 M(+10.7%)
Jun 2016
-
$3.39 M(+25.8%)
$10.89 M(+11.9%)
Mar 2016
-
$2.70 M(+14.0%)
$9.74 M(+10.2%)
Dec 2015
$8.84 M(+167.3%)
$2.36 M(-3.2%)
$8.84 M(+15.5%)
Sep 2015
-
$2.44 M(+9.2%)
$7.65 M(+17.0%)
Jun 2015
-
$2.24 M(+24.4%)
$6.54 M(+35.5%)
Mar 2015
-
$1.80 M(+52.9%)
$4.82 M(+45.9%)
Dec 2014
$3.31 M(+1115.4%)
$1.18 M(-11.5%)
$3.31 M(+55.1%)
Sep 2014
-
$1.33 M(+154.4%)
$2.13 M(+165.4%)
Jun 2014
-
$522.00 K(+85.8%)
$803.00 K(+185.8%)
Mar 2014
-
$281.00 K
$281.00 K
Dec 2013
$272.00 K
-
-

FAQ

  • What is Cidara Therapeutics annual SGA?
  • What is the all time high annual SGA for Cidara Therapeutics?
  • What is Cidara Therapeutics annual SGA year-on-year change?
  • What is Cidara Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Cidara Therapeutics?
  • What is Cidara Therapeutics quarterly SGA year-on-year change?
  • What is Cidara Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Cidara Therapeutics?
  • What is Cidara Therapeutics TTM SGA year-on-year change?

What is Cidara Therapeutics annual SGA?

The current annual SGA of CDTX is $18.33 M

What is the all time high annual SGA for Cidara Therapeutics?

Cidara Therapeutics all-time high annual SGA is $20.55 M

What is Cidara Therapeutics annual SGA year-on-year change?

Over the past year, CDTX annual SGA has changed by -$2.21 M (-10.77%)

What is Cidara Therapeutics quarterly SGA?

The current quarterly SGA of CDTX is $4.96 M

What is the all time high quarterly SGA for Cidara Therapeutics?

Cidara Therapeutics all-time high quarterly SGA is $8.20 M

What is Cidara Therapeutics quarterly SGA year-on-year change?

Over the past year, CDTX quarterly SGA has changed by -$3.23 M (-39.45%)

What is Cidara Therapeutics TTM SGA?

The current TTM SGA of CDTX is -$2.00 B

What is the all time high TTM SGA for Cidara Therapeutics?

Cidara Therapeutics all-time high TTM SGA is -$13.30 M

What is Cidara Therapeutics TTM SGA year-on-year change?

Over the past year, CDTX TTM SGA has changed by -$2.01 B (-10525.38%)